Persistent menstruation in transgender people using testosterone gender-affirming hormone therapy
Persistent menstruation >6 months after commencing testosterone GAHT may be impacted by body mass index and the mode of testosterone administration. This is important information for individuals considering testosterone GAHT as well as for clinicians advising on the benefits and drawbacks of different forms of testosterone administration as well as the likelihood of menstrual cessation.
Authors
- Sonia Grover (ORCID: https://orcid.org/0000-0001-5183-2892)
- Kalen Eshin
- Ada S. Cheung (ORCID: https://orcid.org/0000-0001-5257-5525)
- Laura Burchill (ORCID: https://orcid.org/0000-0003-0959-7248)
- Sav Zwickl (ORCID: https://orcid.org/0000-0003-2959-5928)
- Lachlan M. Angus (ORCID: https://orcid.org/0000-0002-5842-6173)
- Shalem Leemaqz (ORCID: https://orcid.org/0000-0003-4616-8426)
- Alex Fang Qi Wong (ORCID: https://orcid.org/0000-0002-3666-5261)
- Charlotte Elder (ORCID: https://orcid.org/0000-0003-2390-5593)
- Teddy Cook (ORCID: https://orcid.org/0000-0001-5741-6013)
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- Flinders University (AU)
- La Trobe University (AU)
- Mercy Hospital for Women (AU)
- UNSW Sydney (AU)
- Austin Health (AU)
Publication Details
- Journal
- International Journal of Transgender Health
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1080/26895269.2024.2403140
- Citations
- 4
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 2.57
Funders
- National Health and Medical Research Council